A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor response
暂无分享，去创建一个
L. Álvarez-Vallina | B. Blanco | J. Bonet | J. Rodríguez-Peralto | M. Compte | L. Sanz | Ángel Ramírez-Fernández | Alejandro Segura-Tudela | L. Rubio-Pérez | S. Lykkemark | Laura Díez-Alonso | Carmen Domínguez-Alonso | R. Navarro | Antonio Tapia-Galisteo | S. Harwood | Ainhoa Erce-Llamazares | Oana Hangiu | Francisco J Blanco | R. Lázaro-Gorines | Francisco J. Blanco | Mariola Ferreras-Gutiérrez | C. Santos | Rodrigo Lázaro-Gorines | Rocío Navarro | Rodrigo Lázaro-Gorines